Abstract: Data processing system for generating representations and analyses of cytometric information for:—loading one set of data including:—one image of two wells on a plate each having one cell in a predetermined biological condition, each image being acquired with a microscope;—features of each cell from each image;—processing loaded data for obtaining representations and analyses of the data, from:—Histogram in one dimension;—Scattergram in two-dimensions;—Density in two-dimensions;—Plate layout management;—Cell montage;—Field;—Plate heatmap;—Dose response with regrouping of replicates;—Statistics information percentage of cell in different gates;—zFactor calculation with regrouping of replicates;—List of well for selection and list of biological condition for selection;—Statistics export capability;—Ready to print layout capability on the selected well or biological condition or all wells and biological conditions.

Abstract: This invention relates to compounds with the formula (I) given below or one of their pharmaceutically acceptable salts, as a medicine; Formula (I) of pharmaceutical compositions comprising one or more compounds with Formula (I) as active constituent, use of compounds with Formula (I) for the preparation of compositions designed to prevent or treat at least one illness involving an abnormal cellular proliferation, pro-apoptotic compositions and/or anti-proliferative compositions comprising at least one compound with Formula (I)/and the use of compounds with formula (I) as pro-apoptotic and/or anti-proliferative agents.

Abstract: The invention concerns compounds of formula (I), wherein —XmR1 and YnR2, identical or different are present, or one of the XmR1 or YnR2 is absent and YaR2, identical or different, is present, and in that case the bond between C1 and C2 is a double bond, XmR1 and YnR2 together represent a group A and in that case the bond between C1 and A is a double bond, or their pharmaceutically acceptable salts as medicine.